GlassScriptPhysician profile
Katie Giles
NPI 1225577349
$998.37
in general payments reported to CMS, 2019-2025
20 companies · $318 in 2025
The $318 reported for 2025 was more than what 76% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $147 · 2022: $176 · 2023: $201 · 2024: $156 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $591 · Education: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $590.63 |
| Education | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $147.23 | 2021-2023 | |
| Astellas Pharma US INC | $122.78 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $115.54 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $106.05 | 2024-2025 | Gemtesa, Myfembree |
| Pfizer INC. | $93.22 | 2021-2025 | |
| Sage Therapeutics, LLC | $84.49 | 2024-2025 | Zurzuvae |
| Shield Therapeutics INC | $46.71 | 2023-2025 | Accrufer |
| Exact Sciences Corporation | $40.43 | 2024-2025 | Cologuard Collection Kit |
| Evofem Biosciences, INC. | $37.16 | 2021-2022 | |
| Ethicon US, LLC | $32.69 | 2024 | Ethicon, Surgicel Nu-Knit, Evarrest |
| Mylan Pharmaceuticals INC. | $30.29 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.66 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $18.85 | 2025 | |
| Daiichi Sankyo INC. | $18.59 | 2021 | |
| Supernus Pharmaceuticals, INC. | $14.70 | 2025 | Qelbree |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $14.53 | 2024 | Slynd |
| Millicent US INC | $13.80 | 2023 | Intrarosa |
| Myovant Sciences INC. | $13.64 | 2021 | |
| Hologic Sales and Service, LLC | $12.57 | 2022 | |
| Therapeuticsmd, INC. | $12.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Giles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.